Ceretype Neuromedicine Company
Ceretype Neuromedicine is an AI-based fMRI brain biomarker technology to improve drug discovery and patient care.
Industry:
End-to-end Drug Development, FemTech, United States
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2020-01-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
2
Total Funding:
100000
Last Funding Date:
2023-02-28
Last Funding Type:
Pre-Seed
Register and Claim Ownership